Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo

GAN publication

"Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma". Read more

Global Impact of Respiratory Disease

The second edition of the Global Impact of Respiratory Disease was recently published by the Forum of International Respiratory Societies. Read more

World Asthma Day 2017

Asthma is one of the major noncommunicable diseases, and is an important cause of chronic suffering, disability and preventable deaths in the world. Everyday activities become a huge challenge for the world’s of asthma sufferers, says the Chair of the Global Asthma Network Professor Innes Asher from The University of Auckland. Read more

GAN Indian Investigators Meeting, 26 March 2017

On Sunday 26 March 2017 investigators from all 9 of the Indian GAN centres met at Asthma Bhawan, Jaipur. Read more

Prof Innes Asher appointed to WHO Expert Panel on NCDs

We are delighted to announce that Prof Innes Asher has been appointed to the WHO Expert Panel on NCDs. Read more

GAN publication

"The Global Asthma Network Rationale and Methods for Phase I Global Surveillance: Prevalence, Severity, Management and Risk Factors". Read more

GAN posters at ERS 2016

Two posters relating to GAN research were presented at the 26th European Respiratory Society International Congress, held 3-7 September 2016 in London. Read more

Professor Luis Garcia-Marcos at ATS 2016

Professor Luis Garcia-Marcos is currently at the American Thoracic Society (ATS) meeting in San Francisco, California. He is manning a GAN booth in the Global Community section of the Exhibitor Hall (Booth GC7). The ATS runs from May 13 to 18th. Read more

World Asthma Day 2016 - GAN Press Release

Tuesday 3 May is World Asthma Day – the Theme is “You can control your asthma”. Almost 1000 people die from asthma each day – far more than most people realise. The tragedy is that most of these deaths are potentially preventable. Read more

GAN at the American Thoracic Society meeting 2016

Following the success of the GAN booth at the American Thoracic Society (ATS) in San Diego last year, we are again this year having a GAN booth in the exhibitor’s hall at the ATS 2016 International Conference scheduled for 13-18 May 2016 at the Moscone Center, San Francisco, USA. Read more

  • Global Asthma Report 2014

    The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from
    read more

  • Closing the world data gaps for asthma is a key activity of the Global Asthma Network

    The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from

  • Governments should commit to research, intervention, and monitoring to reduce the burden of asthma in the world

    Asthma is a public health priority as it is a chronic respiratory disease affecting 334 million people worldwide

  • Countries should monitor asthma hospital admissions in children and adults to identify trends in asthma over time

    Hospital admissions need to be monitored to identify trends in asthma over time and prevent epidemics

  • Avoidable asthma deaths are still occurring due to inappropriate management of asthma

    including over-reliance on reliever medication rather than preventer medication

  • Health professionals in all countries should regard frequent or severe recurrent wheezing in infancy as part of the spectrum of asthma

  • Controlled asthma imposes far less of an economic burden than non-controlled asthma

    The yearly costs of poorly managed asthma are 56 billion in the US alone

  • All countries should have effective policy action on known, remediable causes of asthma such as parental smoking (for children) and occupational exposures

  • All countries should have national strategies and action plans to improve asthma management and reduce costs

  • Asthma management guidelines are an essential part of successfully managing asthma and promoting the delivery of quality asthma care

  • All countries should have a list of essential medicines for asthma including both inhaled corticosteroids and a bronchodilator

  • All asthma inhalers procured, distributed, and sold in countries should meet international quality standards

  • Guaranteed access to quality-assured essential asthma medicines is vital to improving asthma outcomes

  • Low-income countries need appropriately trained health professionals and health services organised to manage asthma

  • Asthma is a serious burden in low- and middle-income countries

    Governments in low- and middle-income countries should make asthma a health priority

  • Asthma is an important NCD in all regions of the world, affecting people in non-affluent as well as affluent countries

    Governments should include asthma in all actions from WHO Global Action Plan for NCDs

Funding and development partners

The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:

Asthma Australia
Woolcock Institute of Medical Research
Aix Marseille University
Center of Allergy & Immunology, Tbilisi
Riga Stradins University
New Zealand
The Asthma Foundation of New Zealand
University of Auckland
Auckland Asthma Charitable Trust
University of Murcia
Valencia University
Sultanate of Oman
The Oman Respiratory Society
United Kingdom
The London School of Hygiene and Tropical Medicine
St Georges University of London
UK Medical Research Council